Clinical Trial: A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871214) titled 'A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)' on Oct. 07.

Brief Summary: The purpose of this study is to assess the safety, tolerability, and surgical feasibility of preoperative Pumitamig-based therapy and other molecules in resectable, Early-Stage Non-Small Cell Lung Cancer

Study Start Date: Nov. 30

Study Type: INTERVENTIONAL

Condition: Early-Stage Non-Small Cell Lung Cancer

Intervention: DRUG: Pumitamig

Specified dose on specified days

DRUG: Carboplatin

Specified dose on specified days

D...